EVALUATION OF INNOVATIVE CO-PROCESSED ADDITIVE FOR DIRECT COMPRESSION TABLETS USING ATORVASTATIN AND DIAZEPAM AS MODEL DRUGS

Abstract

Objective: The aim of the present study is to prepare and evaluate a co-processed excipient from commercially available Avecil PH102 and silicon dioxide colloidal (SDC) using direct compression technique for preparation of tablets.Methods: The effect of the ratio of the two components on the properties of the prepared co-processed excipient has been investigated. In addition, it was evaluated for flowability, compressibility, and compatibility utilizing Fourier transforms Infrared (FTIR) and Differential scanning calorimetry (DSC) analysis. Tablets were produced by direct compression utilizing the co-processed additive with diazepam or atorvastatin calcium as model drugs in addition to magnesium stearate and talc as a lubricant. The addition of super disintegrant croscarmellose sodium or tablets preparation by wet granulation was utilized for comparison regarding the properties of prepared tablets. The prepared tablets were characterized for the drug content, hardness, friability, disintegration, dissolution, and stability.Results: Optimal physicochemical properties of the excipient from a manufacturing perspective were obtained using a co-processed Avecil PH102-with SDC (2% w/w) to get a mixture. The FTIR and DSC analysis showed no chemical interaction. The properties of tablets made using co-processed excipient showed good hardness, friability, acceptable tablet disintegration time, dissolution rate, and stability comparable to that obtained by the multistep method of wet granulation. Although the addition of super disintegrant more shorten the disintegration time but the obtained value without croscarmellose sodium is still satisfied the requirement.Conclusion: The Avecil PH102-SDC co-processed excipient produced was found to be promising as a valuable industrial, pharmaceutical excipient for the production of compressed tablets with good physical properties and fast dissolution. 

Authors and Affiliations

Kahtankahtan J. Hasson, Mowafaq M. Ghareeb

Keywords

Related Articles

EVALUTION OF ANTIARTHRITIC ACTIVITY OF LEAF EXTRACTS OF PERGULARIA DAEMIA [FORSK] PLANT IN EXPERIMENTAL ANIMALS

Objective: Pergularia daemia [Forsk] has been used from the long time in traditional medicine. The main objective of this work is to evaluate anti-rheumatic activity of leaf of Pergularia daemia [Forsk]Methods: Anti- art...

PREPARATION AND EVALUATION OF FLOATING EXTENDED RELEASE MATRIX TABLET USING COMBINATION OF POLYMETHACRYLATES AND POLYETHYLENE OXIDE POLYMERS

Objective: The purpose of this study was to prepare non-effervescent floating extended release matrix of Tramadol hydrochloride using polyethylene oxide (PEO) and a combination of cationic and anionic polymethacrylates p...

VALIDATION FOR QUANTITATIVE OF METHADONE ENANTIOMERS AND ITS MAJOR METABOLITE USING VANCOMYCIN COLUMN COUPLED WITH MASS SPECTROMETRIC DETECTION AND ITS APPLICATION TO CLINICAL SAMPLES

Objective: To develop method to measure both methadone enantiomers and its major metabolite 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP) in clinical samplesMethods: Five hundredmicroliters plasma/serum was...

FORMULATION, OPTIMIZATION AND EVALUATION OF FLOATING TABLETS CLARITHROMYCIN

Objective: The present aim of this study was to formulate, optimize and evaluation of floating tablets of Clarithromycin.Methods: Floating tablets of Clarithromycin were formulated using polymer HPMC K15M with sodium bic...

DNA TARGETED ANTHRAQUINONE DERIVATIVES: AN IMPORTANT ANTICANCER AGENTS

Deoxyribonucleic acid, DNA is the source of various genetic information and is currently one of the most important and studied biological receptor. Lately, a wide range of chemotherapeutic agents are known wherein they a...

Download PDF file
  • EP ID EP577871
  • DOI -
  • Views 83
  • Downloads 0

How To Cite

Kahtankahtan J. Hasson, Mowafaq M. Ghareeb (2016). EVALUATION OF INNOVATIVE CO-PROCESSED ADDITIVE FOR DIRECT COMPRESSION TABLETS USING ATORVASTATIN AND DIAZEPAM AS MODEL DRUGS. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 201-207. https://europub.co.uk/articles/-A-577871